RIVA-CARVEDILOL DIN 02567024
Health Canada record
| Active ingredient(s) | CARVEDILOL 25 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C07AG02 CARVEDILOL |
| Original market date | |
| Current status date | 26-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Laboratoire Riva Inc. — licence 100179, currently licensed, last inspection rating C (2026-01-12).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CARVEDILOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248752 | CARVEDILOL | SIVEM PHARMACEUTICALS ULC | Tablet | CARVEDILOL 3.125 MG | Marketed |
| 02324520 | CARVEDILOL | PRO DOC LIMITEE | Tablet | CARVEDILOL 12.5 MG | Marketed |
| 02324512 | CARVEDILOL | PRO DOC LIMITEE | Tablet | CARVEDILOL 6.25 MG | Marketed |
| 02324504 | CARVEDILOL | PRO DOC LIMITEE | Tablet | CARVEDILOL 3.125 MG | Marketed |
| 02324539 | CARVEDILOL | PRO DOC LIMITEE | Tablet | CARVEDILOL 25.0 MG | Marketed |
| 02248755 | CARVEDILOL | SIVEM PHARMACEUTICALS ULC | Tablet | CARVEDILOL 25 MG | Marketed |
| 02248754 | CARVEDILOL | SIVEM PHARMACEUTICALS ULC | Tablet | CARVEDILOL 12.5 MG | Marketed |
| 02248753 | CARVEDILOL | SIVEM PHARMACEUTICALS ULC | Tablet | CARVEDILOL 6.25 MG | Marketed |
| 02245916 | PMS-CARVEDILOL | PHARMASCIENCE INC | Tablet | CARVEDILOL 12.5 MG | Marketed |
| 02245917 | PMS-CARVEDILOL | PHARMASCIENCE INC | Tablet | CARVEDILOL 25 MG | Marketed |
| 02245914 | PMS-CARVEDILOL | PHARMASCIENCE INC | Tablet | CARVEDILOL 3.125 MG | Marketed |
| 02245915 | PMS-CARVEDILOL | PHARMASCIENCE INC | Tablet | CARVEDILOL 6.25 MG | Marketed |
| 02252317 | TEVA-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 6.25 MG | Marketed |
| 02252333 | TEVA-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 25 MG | Marketed |
| 02252325 | TEVA-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 12.5 MG | Marketed |
| 02252309 | TEVA-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 3.125 MG | Marketed |
| 02247934 | APO-CARVEDILOL | APOTEX INC | Tablet | CARVEDILOL 6.25 MG | Dormant |
| 02247936 | APO-CARVEDILOL | APOTEX INC | Tablet | CARVEDILOL 25 MG | Dormant |
| 02247933 | APO-CARVEDILOL | APOTEX INC | Tablet | CARVEDILOL 3.125 MG | Dormant |
| 02247935 | APO-CARVEDILOL | APOTEX INC | Tablet | CARVEDILOL 12.5 MG | Dormant |
| 02344653 | CARVEDILOL | MELIAPHARM INC | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02344637 | CARVEDILOL | MELIAPHARM INC | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02344645 | CARVEDILOL | MELIAPHARM INC | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02229652 | COREG (CARVEDILOL) TABLETS, 12.5MG | GLAXOSMITHKLINE INC | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02229653 | COREG (CARVEDILOL) TABLETS, 25MG | GLAXOSMITHKLINE INC | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02229650 | COREG (CARVEDILOL) TABLETS, 3.125 MG | GLAXOSMITHKLINE INC | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02229651 | COREG (CARVEDILOL) TABLETS, 6.25MG | GLAXOSMITHKLINE INC | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02240810 | COREG 12.5MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02240811 | COREG 25MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02240808 | COREG 3.125MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02240809 | COREG 6.25MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02155680 | DILATREND - TAB 25MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 25 MG | Cancelled Pre Market |
| 02155699 | DILATREND - TAB 50MG | HOFFMANN-LA ROCHE LIMITED | Tablet | CARVEDILOL 50 MG | Cancelled Pre Market |
| 02248749 | DOM-CARVEDILOL | DOMINION PHARMACAL | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02248748 | DOM-CARVEDILOL | DOMINION PHARMACAL | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02248751 | DOM-CARVEDILOL | DOMINION PHARMACAL | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02248750 | DOM-CARVEDILOL | DOMINION PHARMACAL | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02347512 | MYLAN-CARVEDILOL | MYLAN PHARMACEUTICALS ULC | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02347571 | MYLAN-CARVEDILOL | MYLAN PHARMACEUTICALS ULC | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02347555 | MYLAN-CARVEDILOL | MYLAN PHARMACEUTICALS ULC | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02347520 | MYLAN-CARVEDILOL | MYLAN PHARMACEUTICALS ULC | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02246532 | NOVO-CARVEDILOL TABLETS | NOVOPHARM LIMITED | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02246531 | NOVO-CARVEDILOL TABLETS | NOVOPHARM LIMITED | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02246530 | NOVO-CARVEDILOL TABLETS | NOVOPHARM LIMITED | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02246529 | NOVO-CARVEDILOL TABLETS | NOVOPHARM LIMITED | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02362090 | NTP-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 12.5 MG | Cancelled Pre Market |
| 02362082 | NTP-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 6.25 MG | Cancelled Pre Market |
| 02362074 | NTP-CARVEDILOL | TEVA CANADA LIMITED | Tablet | CARVEDILOL 3.125 MG | Cancelled Pre Market |
| 02248716 | NU-CARVEDILOL | NU-PHARM INC | Tablet | CARVEDILOL 6.25 MG | Cancelled (Unreturned Annual) |
| 02248717 | NU-CARVEDILOL | NU-PHARM INC | Tablet | CARVEDILOL 12.5 MG | Cancelled (Unreturned Annual) |
| 02248718 | NU-CARVEDILOL | NU-PHARM INC | Tablet | CARVEDILOL 25 MG | Cancelled (Unreturned Annual) |
| 02248715 | NU-CARVEDILOL | NU-PHARM INC | Tablet | CARVEDILOL 3.125 MG | Cancelled (Unreturned Annual) |
| 02268043 | RAN-CARVEDILOL | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
| 02268035 | RAN-CARVEDILOL | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02268027 | RAN-CARVEDILOL | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02268051 | RAN-CARVEDILOL | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02338114 | ZYM-CARVEDILOL | ZYMCAN PHARMACEUTICALS INC | Tablet | CARVEDILOL 25 MG | Cancelled Post Market |
| 02338092 | ZYM-CARVEDILOL | ZYMCAN PHARMACEUTICALS INC | Tablet | CARVEDILOL 6.25 MG | Cancelled Post Market |
| 02338068 | ZYM-CARVEDILOL | ZYMCAN PHARMACEUTICALS INC | Tablet | CARVEDILOL 3.125 MG | Cancelled Post Market |
| 02338106 | ZYM-CARVEDILOL | ZYMCAN PHARMACEUTICALS INC | Tablet | CARVEDILOL 12.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37192 | 2026-03-26 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for CARVEDILOL
17 valid EDQM Certificates of Suitability from 17 holders. 22 active FDA Drug Master Files.
Request a quote for RIVA-CARVEDILOL